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Background. Idiopathic intracranial hypertension can cause rapid deterioration of visual acuity in some severe cases, and these
cases are usually thought to have “malignant” form of this disease. Case. In this paper, we report on a 16-year-old girl who is a
typical example for malignant idiopathic intracranial hypertension with a rapid recovery of visual acuity after lumboperitoneal
shunt operation. Observations and Conclusions. Malignant form of idiopathic intracranial hypertension must be kept in mind in
selected patients to avoid irreversible visual loss.
1.Introduction
Idiopathic intracranial hypertension (IIH) is a syndrome
of increased intracranial pressure without hydrocephalus
or mass lesion and with normal cerebrospinal ﬂuid (CSF)
composition[1].ThecourseofIIHisgenerallyfavorable,but
rarely severe visual loss may occur progressively, as the result
of chronic papilledema in the late stage of the disease [2]. In
very rare situations, severe visual loss may occur as an acute
event,deﬁningtheso-called“malignant”IIH,andﬁnalvisual
outcome in these patients is variable [3]. We report a case
of IHH presenting with acute, rapidly progressive visual loss
that showed rapid recovery of after lumboperitoneal shunt
operation.
2.CaseReport
A 16-year-old girl referred to our hospital with complaint
of a 9-day history of severe, pulsatile, and continuous
headache with nausea and vomiting. We learned that blurred
vision which was more prominent in her left eye had
started 2 days after the beginning of headache, and she was
brought to a hospital. She was found to have bilateral disk
edema, and a computerized tomography (CT) scan of the
brain was performed and showed normal ﬁndings. Lumbar
puncture (LP) was performed and the opening pressure
was found high. After performing the cranial, orbital, and
cervical magnetic resonance imagings (MRIs), which were
unremarkable, and normal cerebral spinal ﬂuid analysis, she
was referred to our hospital.
On admission, her headache and vomiting was going on,
and we learned that her blurred vision got worse during
this period. Bilaterally papilledema was seen on funduscopic
examination. Extraocular movements were intact, and there
was no ptosis or nystagmus. Her best corrected visual acuity
was0.5intherighteyeand0.005inthelefteye,andwefound
severe concentric visual ﬁeld constriction in her perimetric
visual ﬁeld examination. Other neurological examination
ﬁndings were normal. In her physical examination BMI
was within normal limits (22kg/m2), and signs of sinusitis
were determined. Her medical history was unremarkable
for IIH. Her basic metabolic panel values, thyroid func-
tion test, and parathormone were normal except white
complete blood count indicating thalassemia intermedia.
MR angiography and venography that were performed to
exclude the possibility of a cerebral venous thrombosis were
normal. Laboratory tests for the etiology of IIH (ANA,
Anti-DNA, ANCA, ANA proﬁle, Protein C, S, antithrombin
III resistance, activated protein C resistance, Lyme screen,
Brucella tests, and VDRL) were all normal. A repeated LP2 Case Reports in Ophthalmological Medicine
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Figure 1: The results of patient’s visual ﬁeld examination and corrected visual acuity according to the day of hospitalization.
showed an opening pressure of 380mmHg with normal
CSF analysis. After that, acetazolamide therapy (1000mg
per day, po) and methylprednisolone pulse therapy (1g
per day, iv) were given immediately, but her visual acuity
did not show any improvement. Her best corrected visual
acuity was found 0.5 at the right side and 0.05 at the
left eye. These treatments showed only a minor aﬀect
in her headache, and an emergent lumbar drainage was
performed at the sixth day of the hospitalization. After
starting external lumbar drainage, the patient’s visual acuity
and visual ﬁeld examination showed improvement (best-
corrected visual acuity; 0.5 in the right and 0.2 in the
left eye). With these results, a permanent lumboperitoneal
shunt was planned, and during preoperative preparations
externallumbardrainagewasstopped.After36hours,aright
peripheral facial palsy was observed, and herexternal lumbar
drainage was replaced with a permanent lumboperitoneal
shunt emergently. This treatment stabilized visual symptoms
and was followed by a rapid improvement of visual acuity
after operation. Visual acuity was found 0.9 at the right
side and 0.6 at the left side after the operation. The results
of patient’s visual ﬁeld examinations and corrected visual
acuity according to the day of hospitalization are shown in
Figure 1.
3. Discussion
In general practice, it is well known that visual complaints
are typically absent at presentation of IIH, but aﬀected
visual acuity may occur in the late course of the disease;
in particular, if there is longstanding papilledema. However,
the acuity may deteriorate rapidly in severe cases of IIH
[4, 5]. These cases are usually thought to have “malignant”
or “fulminant” IIH, and our case is a typical example
for malignant IHH. Visual symptoms had nearly started
concurrently with headache in our case and deteriorated
in a few days. Such patients as our case who generally
have marked visual ﬁeld loss or decreased central vision at
presentation require urgent treatments like repeated lumbar
punctures, lumbar drainage, and intravenous steroids [3].
We ﬁrst started diuretic and steroid therapy, but, because of
failed medical therapy and intractable headache and with the
aim of preventing visual acuity, we planned urgent surgical
treatment.
Two goals must be considered when managing patients
with idiopathic intracranial hypertension: prevention of
visual loss and resolution of symptoms. Presence of severe
visual loss (20/40 or worse) in one or both eyes at time
of initial examination is one of the indications for surgeryCase Reports in Ophthalmological Medicine 3
[1]. Our case’s visual acuity was 20/100 in the right eye
and 5/100 in the left eye on admission. It is estimated
that up to 17 percent of patients with IIH will progress to
develop permanent visual loss [3]. The ﬁnal visual outcome
in fulminant IIH is variable but, up to half of the patients,
could become totally blind [6].
Mensah et al. [3] reported that patients with marked
visual ﬁeld constriction and severe visual acuity loss at the
time of onset of the IIH showed only partial response to
therapy with diuretics and steroids and these patients have
suﬀeredclinicallymalignantcoursewithrapidprogressionto
near blindness. In light of the foregoing clinical experiences,
we planned an urgent operation to avoid blindness.
Malomo et al. [7] reported a case with a 4-week history
of persistent of IHH with visual loss and deafness that had
a good response to the nonoperative treatments; however,
Kidron and Pomeranz [8] reported two cases with malignant
IHH and one of these patients underwent lumboperitoneal
shuntoperation.Infact,itisnotwellknownaboutmalignant
form of IHH, and there is no obvious explanation of the
disastrous outcome in these patients, but, in agreement with
occasional reports in the literature, it is strongly suggested
not to squander time so as to protect the patient’s visual
acuity.
As a result, we believe that such cases, as presenting case,
need to be recognized as the malignant end of the spectrum
of IHH, and that their management requires a neurological
emergency. Although rare, keeping this malignant form IHH
inmindandchoosingtherightacutetreatmentoptionmight
cause full recovery of visual acuity in a nearly total blind
patient.
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